A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition:   Irritable Bowel Syndrome Interventions:   Drug: 25mg Eluxadoline;   Drug: 100mg Eluxadoline Sponsor:   Allergan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials

Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Other: Bifidobacterium longum 35624 Sponsors:   Medice Arzneimittel Pütter GmbH & Co KG;   BioTeSys GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2021 Category: Research Source Type: clinical trials

Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Other: Bifidobacterium longum 35624 Sponsors:   Medice Arzneimittel Pütter GmbH & Co KG;   BioTeSys GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2021 Category: Research Source Type: clinical trials

Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Other: dietary treatment Sponsor:   University of Gaziantep Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2021 Category: Research Source Type: clinical trials

Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Other: dietary treatment (low FODMAP);   Other: dietary treatment (gluten free);   Other: dietary treatment (low FODMAP+gluten free);   Other: dietary treatment (Traditional diet recommendations) Sponsor:   University of Gaziantep Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2021 Category: Research Source Type: clinical trials

Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Other: dietary treatment Sponsor:   University of Gaziantep Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2021 Category: Research Source Type: clinical trials

the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Diagnostic Test: H. pylori stool antigen Sponsor:   Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2021 Category: Research Source Type: clinical trials

Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial
This study was designed to assess the efficacy and feasibility of acupuncture in the treatment of IBS.Methods/designThis is a multicenter randomized controlled clinical trial. According to the ratio of 1:1:1, 90 patients with irritable bowel syndrome will be randomly divided into specific acupoints (SA) group, non-specific acupoints (NSA) group, and non-acupoints (NA) group. All patients will be treated with acupuncture 12 times within 4  weeks and followed up for 8 weeks. The primary outcome is the response rate, the percentage of patients whose average value of worst abdominal pain is 30% better and the day...
Source: Trials - April 7, 2021 Category: Research Source Type: clinical trials

The Effects of Carbohydrates in Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Dietary Supplement: Fructan reintroduction;   Dietary Supplement: Placebo reintroduction Sponsors:   Sahlgrenska University Hospital, Sweden;   Atmo Biosciences;   Beneo-Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials

Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study
AbstractObjectivesThese 2 parallel studies (K031 and K032) aim to evaluate the safety of KB109 in addition to supportive self-care (SSC) compared with SSC alone in outpatients with mild to moderate coronavirus disease 2019 (COVID-19). KB109 is a novel synthetic glycan that was formulated to modulate the gut microbiome composition and metabolic output in order to increase beneficial short-chain fatty acid (SCFA) production in the gut. The K031 study is designed to evaluate the safety of KB109 and characterize its impact on the natural progression of COVID-19 in patients with mild to moderate disease. The K032 study is evalu...
Source: Trials - April 2, 2021 Category: Research Source Type: clinical trials

The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: Bifidobacterium breve Bif195;   Dietary Supplement: Placebo Sponsors:   Hvidovre University Hospital;   Chr Hansen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials